DILIC
UTHR icon

Dai-ichi Life Insurance Company’s United Therapeutics UTHR Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.92M Sell
6,617
-769
-10% -$383K 0.11% 172
2025
Q4 		$3.6M Sell
7,386
-510
-6% -$238K 0.09% 193
2025
Q3 		$3.31M Buy
7,896
+1,244
+19% +$418K 0.08% 206
2025
Q2 		$1.91M Sell
6,652
-888
-12% -$265K 0.05% 267
2025
Q1 		$2.32M Sell
7,540
-197
-3% -$67.5K 0.07% 239
2024
Q4 		$2.73M Sell
7,737
-53
-0.7% -$19.5K 0.08% 227
2024
Q3 		$2.79M Sell
7,790
-1,412
-15% -$477K 0.07% 235
2024
Q2 		$2.93M Buy
9,202
+873
+10% +$231K 0.07% 230
2024
Q1 		$1.91M Sell
8,329
-2,561
-24% -$578K 0.04% 306
2023
Q4 		$2.4M Sell
10,890
-660
-6% -$152K 0.05% 274
2023
Q3 		$2.61M Hold
11,550
– – 0.06% 255
2023
Q2 		$2.55M Hold
11,550
– – 0.05% 263
2023
Q1 		$2.59M Buy
+11,550
New +$2.85M 0.06% 261
2019
Q2 		– Sell
-3,000
Closed -$352K – 548
2019
Q1 		$352K Buy
+3,000
New +$350K 0.01% 472

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dai-ichi Life Insurance Company's UTHR Position: Q1 2026 in Review

Dai-ichi Life Insurance Company reduced its United Therapeutics (UTHR) stake by 10% in Q1 2026, selling an estimated $383K and leaving 6,617 shares worth $3.92M. The position accounts for 0.11% of the portfolio, ranked #172.

Dai-ichi Life Insurance Company first reported a position in UTHR in Q1 2019 and has held it in 14 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Dai-ichi Life Insurance Company held 6,617 shares of United Therapeutics worth $3.92M as of Q1 2026.
  • Dai-ichi Life Insurance Company sold 769 United Therapeutics shares in Q1 2026, an estimated $383K.
  • United Therapeutics made up 0.11% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #172 holding.
  • Dai-ichi Life Insurance Company first reported a position in United Therapeutics in Q1 2019 and has held it in 14 quarters since.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.